Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-14T06:50:16.205Z Has data issue: false hasContentIssue false

The Impact of Medical Advances and Lifestyle on Mortality. A Discussion Meeting

Published online by Cambridge University Press:  10 June 2011

Introduction

Studying trends in mortality and morbidity has been at the core of traditional actuarial science since its beginnings. In recent times, the United Kingdom Profession has contributed to such studies in a number of different ways:

(1) through the work of the Government Actuary's Department on the analysis of national data;

(2) through the work of the Continuous Mortality Investigation Bureau on the analysis and graduation of insured lives data;

(3) through the work of various committees established by the Profession, e.g. the Critical Illness Trends Working Party; and

(4) through the work of individual members, or small groups of members, e.g. Richards et al. (2005).

This paper summarises the research resulting from two initiatives by the Profession designed to help actuaries and others to gain a better understanding of trends in morbidity and mortality: the Actuaries Panel on Medical Advances (APMA); and the Mortality Scoping Project.

Type
Sessional meetings: papers and abstracts of discussions
Copyright
Copyright © Institute and Faculty of Actuaries 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chatterjee, T., Macdonald, A.S. & Waters, H.R. (2008a). A model for ischaemic heart disease and stroke I: the model. Annals of Actuarial Science, 3, 4581.CrossRefGoogle Scholar
Chatterjee, T., Macdonald, A.S. & Waters, H.R. (2008b). A model for ischaemic heart disease and stroke II: modelling obesity. Annals of Actuarial Science, 3, 83103.CrossRefGoogle Scholar
Chatterjee, T., Macdonald, A.S. & Waters, H.R. (2008c). A model for ischaemic heart disease and stroke III: applications. Annals of Actuarial Science, 3, 105119.CrossRefGoogle Scholar
Lu, B. (2007). Some new actuarial models of the insurance applications of genetic testing for breast and ovarian cancers. Ph.D. thesis, Heriot-Watt University. http://www.ma.hw.ac.uk/ams/girc/publications.phpGoogle Scholar
Macdonald, A.S. & Roche, E. (2008). How will Trastuzumab affect life insurance? Heriot-Watt University research paper. http://www.actuaries.org.uk/_data/assets/pdf_file/0010/162685/Macdonald_trastuzumab.pdfGoogle Scholar
Macdonald, C. (2008). Scoping mortality research. British Actuarial Journal, 15 (to appear).Google Scholar
Richards, S.J., Kirkby, J.G. & Currie, I.D. (2005). The importance of year of birth in two-dimensional mortality data. British Actuarial Journal, 12, 561.CrossRefGoogle Scholar